Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.
暂无分享,去创建一个
Sylvain Houle | Alan A. Wilson | Sidney H Kennedy | S. Houle | P. Links | S. Kennedy | Gregory M. Brown | T. Blak | S. McMain | J. DaSilva | L. Korman | Jeffrey H Meyer | Alan A Wilson | Gregory M Brown | Thomas Blak | Verdell S. Goulding | Shelley McMain | Lorne Korman | Jean N DaSilva | Rahel Eynan-Harvey | Verdell S Goulding | Paul Links | J. Meyer | V. Goulding | Rahel Eynan-Harvey | Thomas Blak | J. Meyer
[1] B. Barraclough,et al. A Hundred Cases of Suicide: Clinical Aspects , 1974, British Journal of Psychiatry.
[2] Karl J. Friston,et al. Assessing the significance of focal activations using their spatial extent , 1994, Human brain mapping.
[3] A. Peñalva,et al. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man. , 1984, Neuroendocrinology.
[4] B. A. van der Kolk,et al. Trauma and the development of borderline personality disorder. , 1994, The Psychiatric clinics of North America.
[5] KA Smith,et al. Relapse of depression after rapid depletion of tryptophan , 1997, The Lancet.
[6] H. Meltzer,et al. Laterality and 3H-imipramine binding: Studies in the frontal cortex of normal controls and suicide victims , 1991, Biological Psychiatry.
[7] P S Goldman-Rakic,et al. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] C Crouzel,et al. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[9] Karl J. Friston,et al. Spatial registration and normalization of images , 1995 .
[10] V. Arango,et al. Alterations in Monoamine Receptors in the Brain of Suicide Victims , 1992, Journal of clinical psychopharmacology.
[11] B. Jacobs,et al. Life‐span dendritic and spine changes in areas 10 and 18 of human cortex: A quantitative golgi study , 1997, The Journal of comparative neurology.
[12] S. Kapur,et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. , 1999, The American journal of psychiatry.
[13] D. McManus,et al. Chronic administration of the antidepressants phenelzine, despiramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain , 1995, Cellular and Molecular Neurobiology.
[14] G. Elmer,et al. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction. , 1998, Annals of the New York Academy of Sciences.
[15] M. Palkovits,et al. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.
[16] Paul J. Harrison,et al. β-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro: Implications for Antidepressant Therapy , 2000, Neuropsychopharmacology.
[17] H. Meltzer,et al. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. , 1989, The American journal of psychiatry.
[18] C Crouzel,et al. A Method for the In Vivo Investigation of the Serotonergic 5‐HT2 Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and 18F‐Labeled Setoperone , 1990, Journal of neurochemistry.
[19] M. Blais,et al. A psychometric evaluation of the DSM-IV personality disorder criteria. , 1997, Journal of personality disorders.
[20] M. Kleven,et al. Depletion of 5-HT Disrupts Prepulse Inhibition in Rats: Dependence on the Magnitude of Depletion, and Reversal by a 5-HT Precursor , 2002, Neuropsychopharmacology.
[21] V. Arango,et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.
[22] Axel Bossuyt,et al. SPECT imaging of serotonin2 receptors in depression , 1992, Psychiatry Research: Neuroimaging.
[23] Alan A. Wilson,et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. , 2001, The American journal of psychiatry.
[24] C Krogh,et al. "Compendium of pharmaceuticals and specialties". , 1983, Canadian Medical Association journal.
[25] A. Beck,et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. , 1985, The American journal of psychiatry.
[26] E. sanders-Bush,et al. Multiple serotonin receptors: regional distribution and effect of Raphe lesions. , 1981, European journal of pharmacology.
[27] B. McEwen,et al. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.
[28] F. Chaouloff,et al. Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors. , 1997, European journal of pharmacology.
[29] A. Weissman. The Dysfunctional Attitude Scale: A Validation Study , 1979 .
[30] K. Dobson,et al. Cognitive assessment of depression: reliability and validity of three measures. , 1983, Journal of abnormal psychology.
[31] C Crouzel,et al. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. , 1988, European journal of pharmacology.
[32] F. Artigas,et al. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain , 1996, Neuroscience Letters.
[33] D. Kupfer,et al. Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.
[34] W M Grove,et al. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. , 1990, Journal of consulting and clinical psychology.
[35] J. Mann,et al. INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS , 1983, The Lancet.
[36] S. Checkley,et al. A Comparison of the Growth Hormone Responses to Clonidine and Apomorphine in the Same Patients with Endogenous Depression , 1984, British Journal of Psychiatry.
[37] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[38] J. Simiand,et al. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. , 1992, The Journal of pharmacology and experimental therapeutics.
[39] A. Greenshaw,et al. A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition , 2004, Psychopharmacology.
[40] B. Mulsant,et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. , 1999, The American journal of psychiatry.
[41] N. Alpert,et al. Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. , 1996, The Journal of pharmacology and experimental therapeutics.
[42] A. Beck. Cognitive therapy and the emotional disorders: A. T. Beck , 1987, British Journal of Psychiatry.
[43] J. Simiand,et al. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist. , 1993, European journal of pharmacology.
[44] C. Katona,et al. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides , 1990, Brain Research.
[45] I. Ferrier,et al. 5HT2 receptor changes in major depression , 1990, Biological Psychiatry.
[46] G. Aimard,et al. [Study of Beck's hopelessness scale. Validation and factor analysis]. , 1992, L'Encephale.
[47] C. McDougle,et al. Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.
[48] P A Sargent,et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.
[49] E. Pothos,et al. d-fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin. , 1995, Life sciences.
[50] E. Leibenluft,et al. Dysfunctional Attitudes in Borderline Personality Disorder , 1991 .
[51] V. Arango,et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.
[52] M. Fava,et al. Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression. , 1999, Journal of affective disorders.
[53] J. Baron,et al. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[54] E. Robins,et al. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. , 1959, American journal of public health and the nation's health.
[55] I. Miller,et al. Characteristics of depressed patients with elevated levels of dysfunctional cognitions , 1988, Cognitive Therapy and Research.
[56] J. Oliver,et al. The Dysfunctional Attitude Scale: Psychometric properties and relation to depression in an unselected adult population , 1985, Cognitive Therapy and Research.
[57] P. Liddle,et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. , 2000, Archives of general psychiatry.
[58] Gregory M. Brown,et al. Dose-response profiles of plasma growth hormone and vasopressin after clonidine challenge in man , 1990, Psychiatry Research.
[59] G. Curzon,et al. Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine , 1994, Neuropharmacology.
[60] D. Chuang,et al. Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum , 1987, Journal of neurochemistry.
[61] M. Åsberg,et al. "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.
[62] C. Benkelfat,et al. Relapse of depression after rapid depletion of tryptophan , 1997, The Lancet.
[63] Bryan L Roth,et al. Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists , 2001, Brain Research Bulletin.
[64] K. Silk,et al. Biological implications of childhood sexual abuse in borderline personality disorder. , 1997, Journal of personality disorders.
[65] C. Stockmeier,et al. In vivo regulation of the serotonin-2 receptor in rat brain. , 1986, Life sciences.
[66] Ralph Myers,et al. Assessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates , 1999, NeuroImage.
[67] M. Åsberg,et al. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls , 1981, Psychiatry Research.
[68] A. Simons,et al. The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. , 1984, Archives of general psychiatry.
[69] A. Beck,et al. Prediction of eventual suicide in psychiatric inpatients by clinical ratings of hopelessness. , 1989, Journal of consulting and clinical psychology.
[70] C. Fischette,et al. Effects of 5, 7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography , 1987, Brain Research.
[71] Stanley J. Watson,et al. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide , 1997, Biological Psychiatry.
[72] J. Leysen,et al. 5‐HT2 Receptors, Roles and Regulation , 1990, Annals of the New York Academy of Sciences.